Nortylin

Quick links to important sections

Nortylin

Method of action: Antidepressant, Psychoanaleptics

Treatment option: Depression

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Nortylin

Property Description
Active Ingredient Nortriptyline Hydrochloride
Form Capsule, Tablet, Oral Solution
Pharmacological Class Tricyclic Antidepressant (TCA)
General Purpose Mood and Neurochemical Stabilization
Origin Synthetic Compound

Nortylin is a prescription-only psychoactive medicine containing the active ingredient Nortriptyline Hydrochloride, a compound clinically recognized for its use in managing conditions related to mood disorders. The medication is classified as a Tricyclic Antidepressant (TCA), positioning it within a well-established group of drugs designed to modulate the central nervous system. Nortriptyline is specifically a secondary amine tricyclic compound, which provides it with a distinct pharmacological profile; this chemical structure is known to influence the brain's norepinephrine system more selectively compared to earlier TCA agents.


Composition and Form

The product is a synthetic, single-entity product, meaning it is chemically synthesized rather than naturally derived and contains only Nortriptyline Hydrochloride as the sole active substance. Nortylin is prepared for oral administration, and is typically available as either a solid dosage form, such as a capsule or tablet, or occasionally as an oral solution. The specific presentation as capsules is a frequent feature of the brand, contrasting with formulations primarily available as tablets. This formulation is combined only with standard inactive pharmaceutical excipients and fillers appropriate for safe and effective ingestion.


General Purpose

The general purpose of Nortylin is to act as a stabilizing psychotropic agent, assisting in the restoration of a more balanced chemical environment in the brain. The drug's therapeutic role involves modulating the availability of naturally occurring neurochemical messengers, such as norepinephrine, which are essential for regulating functions related to emotion and mood. By helping to stabilize these key signaling chemicals, the medication addresses underlying imbalances to support overall emotional well-being, confirming its long-standing place in psychotropic therapy.

What side effects are possible with Nortylin?

Possible Side Effects and Safety Information

The safety profile of Nortylin (Nortriptyline Hydrochloride) is formally documented in government regulatory labeling, categorizing risks by frequency and the body system affected. The most frequently documented adverse reactions are associated with the drug’s anticholinergic activity and its effects on the cardiovascular system.

Classification Examples of Officially Documented Effects
Very Common Dry mouth, constipation, dizziness, blurred vision, tremor, and tachycardia (fast heart rate) .
Common Drowsiness, confusion, and orthostatic hypotension (low blood pressure upon standing).
Rare Serious effects such as bone marrow depression, agranulocytosis, and seizures.

Serious adverse reactions documented in official sources include the risk of suicidal ideation and behavior (suicidality), particularly in young adults (ages leq 24) upon treatment initiation or dose change, as well as myocardial infarction, stroke, and arrhythmias.

Safety Considerations and Restrictions

Official documents note specific safety considerations for certain populations. Older adults are particularly susceptible to experiencing confusion, agitation, and postural hypotension. Close monitoring is advised for patients with pre-existing cardiovascular disease due to the drug’s potential to affect heart conduction time.

Time-related safety patterns indicate that the risk of suicidal thoughts and agitation is higher during the initial months of therapy. Abrupt discontinuation of prolonged therapy is documented to lead to withdrawal symptoms.

Safety restrictions prohibit the use of Nortylin concurrently with Monoamine Oxidase Inhibitors (MAOIs) due to the risk of Serotonin Syndrome. It is also contraindicated during the acute recovery period following a recent heart attack, and caution is advised in cases of angle-closure glaucoma or Brugada syndrome.

Overdose and Emergency Response

Nortylin Overdose and When to Seek Help

Nortriptyline (sold as Nortylin) is a tricyclic antidepressant, and overdose can lead to severe, life-threatening toxicity affecting the heart and central nervous system. Immediate medical attention is crucial if an overdose is suspected, as symptoms can progress rapidly.

Symptoms of Overdose

Symptoms of a Nortylin overdose may vary in severity and typically appear within two to six hours of ingestion. They may include:

System Mild to Moderate Symptoms Severe Symptoms
Cardiovascular Fast heart rate (sinus tachycardia) Irregular heart rhythm (arrhythmias), low blood pressure (hypotension), changes on ECG (e.g., QRS widening)
Neurological Drowsiness, confusion, agitation, tremors Seizures, coma, central nervous system depression
Anticholinergic Dry mouth, dilated pupils, fever, decreased bowel sounds (ileus) Altered mental status, severe urinary retention

When to Seek Immediate Help

Call emergency services or a Poison Control Center immediately if you or someone else has taken more than the prescribed dose, even if the person appears well. Early intervention is essential for managing potential toxicity. If any of the following severe symptoms are present, do not wait; seek emergency medical care immediately:

  • Seizures or convulsions
  • Severe drowsiness or unresponsiveness (coma)
  • Any irregular or very fast heartbeat or chest pain
  • Trouble breathing or significant low blood pressure

Therapeutic Uses of Nortylin

Main Uses and Therapeutic Benefits of Nortylin

Nortylin is commonly used to help with groups of symptoms that interfere with daily functioning and create noticeable physiological strain, particularly those related to systemic imbalance or increased discomfort and tension. The medication is applied across domains where additional symptomatic support is needed, including the management of certain forms of depression, chronic nerve pain (neuropathy), and as a preventative measure for recurrent migraine headaches. It provides support that helps ease the overall symptom burden and contributes to improved comfort during periods of heightened symptoms.

This medication is applied in addressing conditions marked by symptoms of increased neurological or muscular activity, such as shooting or burning sensations, which often co-occur with symptoms of emotional distress. It provides support that helps ease the overall symptom burden and contributes to improved comfort during periods of heightened symptoms. This makes it particularly relevant when supportive symptom management is appropriate, assisting with maintaining functional stability when symptoms become more noticeable.

Quick Fact: Support for Symptoms that Interfere with Daily Functioning

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

The eligibility for using Nortylin (Nortriptyline Hydrochloride) is defined by official regulatory bodies, setting clear restrictions for specific patient groups and clinical conditions.

Contraindicated Populations (Must Not Use)

Use is strictly contraindicated for individuals who:

  • Have known hypersensitivity to Nortriptyline or similar tricyclic antidepressants.
  • Are in the acute recovery period following a recent myocardial infarction (MI) [1.1, 1.8].
  • Are concurrently using a Monoamine Oxidase Inhibitor (MAOI), including linezolid or intravenous methylene blue [1.1].
  • Have discontinued an MAOI within the last 14 days [1.1].

Age-Related Eligibility

Age Group Regulatory Status
Children & Adolescents (<18) Not approved in the US; Not recommended in most regions due to unestablished safety and efficacy [1.1, 2.3].
Older Adults (Geriatrics) Requires close supervision; lower dosages are recommended due to increased sensitivity and potential for age-related cardiac or liver issues [1.3].

Condition-Specific Limitations

Use requires great caution and close supervision in patients with certain pre-existing conditions, as documented in official labeling, including:

  • Cardiovascular Disease (due to risk of tachycardia and conduction time changes) [1.6].
  • Narrow-Angle Glaucoma or a history of urinary retention [1.6].
  • Hepatic Impairment (liver problems) [3.4].
  • Schizophrenia or Manic-Depressive Disorder (due to risk of exacerbation) [2.2].

Pregnancy and Lactation Status

Safe use has not been established during pregnancy or lactation [1.8]. The potential benefits must be weighed against possible hazards in women of childbearing potential, as per regulatory guidance [1.8].

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define the interaction profile of Nortriptyline (referred to as Nortylin in this context) primarily through pharmacokinetic and pharmacodynamic mechanisms that lead to constraints on its concurrent use with other agents.

Key interaction domains include:

  • Monoamine Oxidase Inhibitors (MAOIs): Concurrent use, including with nonpsychiatric MAOIs like linezolid, is contraindicated. A mandatory 14-day washout period is required between stopping either agent and starting the other due to the high risk of developing life-threatening Serotonin Syndrome.

  • CYP2D6 Inhibitors: Strong inhibitors of the CYP2D6 enzyme, such as quinidine or cimetidine, can significantly reduce Nortriptyline's metabolism. This action increases its concentration in the body, which may necessitate regulatory guidance to avoid concurrent usage or manage the interaction due to potential toxicity.

  • QT-prolonging Agents: Nortriptyline is associated with a risk of QTc interval prolongation. Coadministration with other medicinal products that also prolong the QTc interval (e.g., sotalol, pimozide) is generally contraindicated or restricted, as this combination increases the risk of serious cardiac arrhythmias like Torsade de pointes.

  • Serotonergic Agents: Combination with other drugs that increase serotonin levels (e.g., SSRIs, SNRIs, triptans, and lithium) is noted as a serious interaction that increases the risk of Serotonin Syndrome. Furthermore, the concurrent consumption of alcohol is strongly advised against due to increased central nervous system (CNS) depressant effects.

Mechanism of Action

How Nortylin works

Nortylin (nortriptyline) exerts its primary action by binding to the norepinephrine transporter (NET) on the presynaptic membrane, functioning as a reuptake inhibitor. This mechanism blocks the reabsorption of the neurotransmitter norepinephrine (NE), thereby increasing its concentration within the synaptic cleft. This increased synaptic availability modulates the signaling output of noradrenergic pathways in the central nervous system, influencing the function of circuits associated with stress responses and specific sensory perception.

Nortylin also engages in a secondary interaction by moderately inhibiting the serotonin transporter (SERT). This results in the dual-modulation of the monoaminergic system, altering downstream activity in pathways associated with affective processing. Additionally, the drug acts as an antagonist at several non-monoaminergic receptors, including the histamine H1 receptor and muscarinic acetylcholine receptors (mAChR). H1 receptor antagonism induces a sedative physiological consequence, while mAChR antagonism alters the activity of the cholinergic system, impacting autonomic functions such as salivary secretion and smooth muscle contraction.

Dosage and Administration Information

How to Use Nortylin: Administration Guidelines

Nortylin (Nortriptyline Hydrochloride) is administered strictly via the oral route and is available in formulations such as capsules and an oral solution.

Standard Dosing and Frequency

Administration follows a cautious titration principle, beginning with a low initial dose and gradually increasing to find the appropriate maintenance level. The standard adult regimen for treatment typically starts at 25 mg taken multiple times daily, or 50 mg as a single dose.

Dosing Pattern Guideline
Usual Adult Maintenance Range Generally between 75 mg and 100 mg daily.
Maximum Outpatient Dose Dosages exceeding 150 mg daily are generally not recommended for outpatients.
Daily Frequency The total daily dose may be given in divided doses or as a single daily dose, often taken at bedtime.

Administration Conditions and Special Populations

Nortylin may be taken with or without food. When the oral solution is used, a specially marked measuring device must be used to ensure precise dosing.

For older adults and adolescents, a reduced starting dose is used, typically beginning at 10 mg to 20 mg daily and slowly advancing to a lower maintenance range of 30 mg to 50 mg per day. If total daily doses exceed 100 mg, monitoring of plasma nortriptyline levels is advised. Discontinuation of the medicine must be gradual, as abrupt cessation is avoided to prevent the occurrence of withdrawal effects.

Recent Clinical Evidence

Nortylin: Recent Clinical Evidence

Evidence for Use in Major Depressive Disorder (MDD)

Nortylin was studied for its use in managing symptoms associated with major depressive disorder, which is the context for its studied indication. The core evidence is derived from Randomized Controlled Trials (RCTs), comparative studies, and meta-analyses that examined outcomes related to systemic or functional imbalance over defined time intervals. These studies primarily included adults diagnosed with depression, and some research was conducted in specific groups like older adults. Researchers monitored outcomes by measuring change in depressive symptom severity and documenting the proportion of participants reaching symptom response or remission. The findings describe patterns observed where changes were measured during the short-term study period, typically lasting 6 to 12 weeks.


Evidence for Use in Chronic Neuropathic Pain

Nortylin was evaluated in a research setting for its use in managing chronic nerve pain, including specific types such as diabetic neuropathy and postherpetic neuralgia. The studies conducted primarily consisted of randomized, double-blind trials and systematic reviews that examined outcomes related to physical discomfort. Researchers focused on patient-reported outcomes, specifically measuring changes in pain intensity scores and the proportion of participants reporting a defined level of pain relief. Findings indicate patterns related to short-term symptom changes, but the primary evidence base is often characterized by small sample sizes and limited follow-up durations.


Research Limitations and Uncertainty

The research highlights areas where data remains insufficient. For instance, long-term effects are not fully established for several conditions, meaning research does not determine whether an individual responds similarly over many years. Furthermore, research has evaluated groups that included participants with comorbidities but data for specific complex subgroups remain insufficient. The medication is not approved for use in children or adolescents. Additionally, comparative evidence is lacking for direct, modern head-to-head trials against all current, first-line treatments. Overall, the evidence quality varies across studies, leading to low certainty in some areas.

Key Studies & References

  1. Antidepressants for smoking cessation (Cochrane Review)

Frequently Asked Questions (FAQ)

Common questions about Nortylin (FAQ)

Q: Does Nortylin cause weight gain?

Official regulatory labeling confirms that weight gain is a documented adverse reaction associated with the use of Nortylin. This effect has been reported in patients taking the medication.


Q: What happens if I forget to take my Nortylin dose?

For patients taking Nortylin once daily at bedtime, the official guidance advises the patient to skip the missed dose. The guidance recommends waiting until the next night's scheduled dose to avoid taking the medicine at a time that could cause daytime sleepiness or affect concentration.


Q: Does Nortylin have a generic version available?

The active ingredient in Nortylin, which is Nortriptyline Hydrochloride, is widely available in generic formulations. These generic versions, which contain the same active chemical substance, are manufactured by various companies.


Q: Can I use Nortylin if I have high blood pressure?

The official safety information notes that Nortylin may affect blood pressure, with both an increase (hypertension) and decrease (hypotension) documented as possible adverse effects. The safety information specifies that the drug's use requires caution and supervision for patients with a history of cardiovascular disease.


Q: How does Nortylin interact with caffeine or energy drinks?

Nortylin may interact with certain substances classified as CNS stimulants, which includes ingredients like caffeine found in energy drinks. This interaction can potentially enhance sympathetic nervous system activity. Regulatory documents warn that this interaction could, in rare cases, provoke a hypertensive crisis (a sudden, severe increase in blood pressure).


Q: Is Nortylin considered a controlled substance?

Nortylin is classified as a prescription-only medicine, meaning it must be dispensed by a licensed pharmacy with a valid prescription. However, regulatory bodies, such as the U.S. Drug Enforcement Administration, have confirmed that the medication is not scheduled as a controlled substance.


Q: What are the common signs of an allergic reaction to Nortylin?

Official prescribing information indicates that the drug should be discontinued promptly if any allergic manifestations occur. While the most common adverse reaction lists do not specify exact allergic signs, official patient information states that any signs of hypersensitivity require immediate notification of a healthcare provider.


Q: What should I do if I experience unexpected side effects from Nortylin?

Official patient guidance states that contact with a healthcare provider is required right away to report any new or sudden changes in mood, behavior, thoughts, or feelings (such as agitation or restlessness). This is a necessary step for managing any symptoms that cause concern while taking the medicine.


Q: Is it normal to feel a change in appetite after starting Nortylin?

Official regulatory documents list a change in appetite, specifically loss of appetite, as a documented adverse effect. This change is sometimes reported by patients when they start taking the medication.


Q: Is there a risk of dependence or addiction with Nortylin?

Regulatory documents state that Nortylin is generally not indicative of addiction. However, patients who abruptly stop the medication after prolonged use may experience withdrawal symptoms. For this reason, official instructions require that the medication be discontinued gradually.


Q: Does taking Nortylin affect blood sugar levels?

The official prescribing information documents that Nortylin may affect blood sugar levels in some patients. Regulatory sources include reports of both elevations and lowerings of blood glucose levels.


Q: How long does Nortylin stay in your system after stopping treatment?

The body metabolizes Nortylin relatively slowly compared to some other medications. Due to this slow elimination, the active substance is known to remain present in the system for an extended period of time after the final dose is taken.


Q: Why do some people experience initial jitters or anxiety when starting Nortylin?

Official regulatory information documents that some individuals may experience mild nervousness when first starting Nortylin treatment. This initial effect typically improves over time as the body adjusts to the medication.


Q: What kind of studies are currently being done on Nortylin?

Government-run resources document that Nortylin is currently being evaluated in clinical trials for investigational uses outside of its studied indication. For example, it is documented that the medication is being assessed for the management of symptoms associated with a condition called Idiopathic Gastroparesis.


Q: What should I know about Nortylin and thyroid conditions?

The official safety information specifies that the administration of Nortylin requires extreme caution and monitoring in patients with hyperthyroidism (an overactive thyroid condition). This is due to the potential risk of developing cardiac arrhythmias (irregular heart rhythms) when the two are combined.


Q: Can Nortylin cause sexual side effects?

Official safety documentation includes the possibility of sexual side effects among the documented adverse reactions. These effects are noted as potentially causing a decreased sexual desire or ability and, in rare instances, an increase in sexual desire or ability.


Q: Does Nortylin interact with nicotine or smoking products?

Official guidance indicates that use of Nortylin concurrently with products that contain nicotine, such as nicotine patches, should only occur under the close supervision of a healthcare provider. This is because nicotine has the potential to influence the effects of the drug.


Q: How is Nortylin different from similar medications I see online?

According to official sources, Nortylin is classified as a Tricyclic Antidepressant (TCA), which places it in an older and distinct pharmacological class compared to many newer agents. Its mechanism is characterized by a primary focus on the brain's norepinephrine system. This mechanism, along with its specific anticholinergic properties, gives it a unique profile among psychotropic medicines.


Q: Can Nortylin affect my sleep or cause insomnia?

The official prescribing information notes that drowsiness is a common side effect of Nortylin. This is related to the drug's mechanism, which includes blocking the histamine H1 receptor, producing a sedative consequence. While drowsiness is common, insomnia is generally not listed among the most frequently reported adverse effects.


Q: What should I know about taking Nortylin with other non-prescription supplements?

Official documents advise caution and consultation regarding concurrent use of any non-prescription medicines, herbal products, or vitamin supplements. This is because some supplements, such as Goldenseal, may interfere with the way the body metabolizes (processes) Nortylin.


Q: Are there any long-term health concerns associated with Nortylin use?

The official safety documentation includes warnings about the risk of serious cardiovascular events, such as arrhythmias, myocardial infarction (heart attack), and stroke. These factors are considered in the long-term risk profile of the medication. Additionally, published research has noted that the long-term effects of the drug for many conditions are not yet fully established.


Q: What are the official uses of Nortylin in different countries?

Official regulatory documents indicate that Nortylin's primary studied and approved indication is the management of symptoms associated with Major Depressive Disorder (MDD). This condition forms the basis for its regulatory approval across various jurisdictions globally. The drug has also been evaluated in research settings for other conditions, such as chronic nerve pain.


Q: Why does Nortylin require regular monitoring by a healthcare provider?

Official patient guidance states that regular monitoring by a healthcare provider is important to ensure the proper management of the medication. This monitoring often includes blood tests to check for any unwanted effects and to help the provider determine the most appropriate dosage adjustment for the individual.


Q: Can Nortylin affect my ability to drive or operate machinery?

The prescribing information contains an explicit warning that Nortylin may impair the mental and/or physical abilities required for performing hazardous tasks. This caution applies specifically to activities like operating machinery or driving a car.


Q: What are the official restrictions for people with a history of seizures and Nortylin?

The official safety information lists seizures as a rare, documented adverse reaction associated with Nortylin. Due to this risk, the drug is generally advised to be used with caution and close supervision for individuals with a history of a seizure disorder.


Q: Can Nortylin interact with common over-the-counter pain relievers?

Official regulatory documents advise against taking non-prescription (over-the-counter or OTC) medicines without first consulting a healthcare provider. This is because many common OTC products, including pain relievers, have the potential to interact with Nortylin.


Q: Can taking Nortylin impact my concentration or memory?

Nortylin is known to have anticholinergic properties, which can affect the central nervous system. Officially documented side effects like confusion and drowsiness may consequently impact cognitive functions, including memory and concentration.


Q: Is the tiredness I feel when starting Nortylin temporary?

Official patient information states that some common initial side effects, such as drowsiness, are generally expected to be mild in nature. These effects often tend to reduce over time or after a few doses as the body adjusts to the medication.


Q: Is Nortylin a daily medication, or can it be taken as needed?

Nortylin is prescribed as a medication intended for daily administration and continuous therapy, particularly for its studied use in major depressive disorder. The official dosing regimen involves establishing a continuous maintenance dose rather than being taken on an as-needed basis.

How should Nortylin be stored and disposed of?

Nortylin Storage and Disposal Instructions

Nortylin must be stored at controlled room temperature, specifically between 20 C to 25 C (68 F to 77 F). The medication should be kept in a dry place and protected from moisture. The container must be kept tightly closed to maintain product stability.


Protection and Handling

It is a mandatory safety requirement to keep Nortylin out of the sight and reach of children.


Disposal Requirements

Unused or expired Nortylin should not be flushed down a drain or toilet. The official method for disposal is to mix the medicine with an unappealing substance, such as dirt or used coffee grounds. This mixture must then be placed into a sealed bag or container before being discarded in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nortylin found in:

A-Z Index: